10th Anti-infectives Partnering and Deal-Making Conference (AIPDM)
Organization: GTC Conferences
|Event Date/Time: Jul 08, 2013 / 8:00 am - (PST)||End Date/Time: Jul 10, 2013 / 5:00 pm - (PST)|
|Abstract Submission Date: Jun 08, 2013|
GTC's 10th Anti-infectives Partnering and Deal-Making Conference, taking place on July 8-10, 2013 in Boston, MA, will contribute to the on-going battle against the ever-changing infectious threats by having experts with direct experiences in the field discuss a wide variety of topics on infectious diseases. The agenda also allows time for networking and opportunities to interface with speakers and fellow delegates in a collegial setting. Previous GTC conferences have been catalytic to several successful partnerships and in 2013 we expect this trend to continue. GTC’s Anti-Infectives Partnering & Deal Making is an infectious disease partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant anti-infective issues and deals that will affect the industry. This event also provides a unique venue for attendees to learn about the anti-infective business development trends, the infectious disease markets, and novel technologies that shape up the industry. Sessions of the conference include: Multi Drug Resistant Gram Negative Infections C-Difficile Infections Regulatory Guidance and Overcoming Challenges in Anti-infectives Development Recent Advances in Anti-Infectives Neglected Infectious Diseases Old Drugs, New Drugs Novel Diagnostics Against Drug Resistance Government Collaborations and Non-dilutive Funding There will also be several interactive Panel Discussions on: Current Trends and Future in Anti-infectives Development Licensing vs Co-development Partnerships Investment Opportunities with Venture Capitalists Finding the Middle Ground in Partnerships with Big Pharma and Govt. Register 3 for the price of 2 with the coupon code rcdvb!
John M. Clerici Principal Tiber Creek Partners Yuan-Hua Ding Senior Director & Head of External R&D Innovation - Asia, Pfizer Worldwide Research & Development Pfizer Michael Dudley Senior Vice President, Research & Development and Chief Scientific Officer Rempex Pharmaceuticals Steven C. Gilman Executive Vice President, Research & Development; Chief Scientific Officer Cubist Pharmaceuticals Pat Horn Chief Medical Officer Tetraphase Pharmaceuticals Malcolm Kendall President and Chief Executive Officer Indel Therapeutics Michael Kurilla Director, Office of Biodefense Research Affairs; Associate Director, Biodefense Product Development National Institute of Allergy and Infectious Diseases Chris Longshaw Associate Director, Microbiology Astellas Pharma Europe Mark Shirtliff Associate Professor University of Maryland School of Medicine Philippe Villain-Guillot Chief Executive Officer Nosopharm SAS